January 18, 2022
MilliporeSigma’s Melanie Brandl, Ph.D. explains how Cellvento® 4CHO-X Expansion Medium supports high cell growth and viability at the N-1 stage in perfusion mode, enabling inoculation of production bioreactors at higher cell densities for reduced lag times and higher final titers.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.